Skip to main content
. 2013 May 15;54(5):3400–3409. doi: 10.1167/iovs.12-11068

Figure 6.

Figure 6

ARS induced p38MAPK activation in HUVECs. ARS activated p38MAPK in time-dependent manner (A) and concentration-dependent manner (B). Specific p38MAPK inhibitors SB202190 and SB203580 inhibited ARS-activated p38MAPK (C). SB202190 and SB203580 protected cells from ARS-induced apoptosis (D) and (E). n = 3. ** denotes P < 0.01.